Last reviewed · How we verify

Ferric Trihydroxide — Competitive Intelligence Brief

Ferric Trihydroxide (FERRIC HYDROXIDE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: ferric hydroxide. Area: Gastroenterology.

phase 2 ferric hydroxide Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Ferric Trihydroxide (FERRIC HYDROXIDE). Ferric Trihydroxide works by binding to iron in the body, potentially helping to remove excess iron and alleviate associated conditions.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ferric Trihydroxide TARGET FERRIC HYDROXIDE phase 2 ferric hydroxide

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (ferric hydroxide class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ferric Trihydroxide — Competitive Intelligence Brief. https://druglandscape.com/ci/ferric-hydroxide. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing